Published in Virology on February 15, 1998
A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev (2010) 4.64
Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis (2011) 2.59
Person-to-person transmission of Andes virus. Emerg Infect Dis (2005) 1.94
Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America. J Clin Microbiol (2000) 1.94
Identifying rodent hantavirus reservoirs, Brazil. Emerg Infect Dis (2004) 1.58
Human pathogenic hantaviruses and prevention of infection. Hum Vaccin (2011) 1.40
Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol (2003) 1.31
Transmission study of Andes hantavirus infection in wild sigmodontine rodents. J Virol (2004) 1.31
Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol (2002) 1.27
Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. J Virol (2007) 1.27
Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol (2011) 1.26
Ecology, genetic diversity, and phylogeographic structure of andes virus in humans and rodents in Chile. J Virol (2008) 1.24
First human isolate of Hantavirus (Andes virus) in the Americas. Emerg Infect Dis (2002) 1.21
Treatment of hantavirus pulmonary syndrome. Antiviral Res (2007) 1.21
DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS). PLoS One (2012) 1.18
Extensive host sharing of central European Tula virus. J Virol (2010) 1.18
Temporal and spatial analysis of Sin Nombre virus quasispecies in naturally infected rodents. J Virol (1999) 1.18
Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog (2011) 1.17
Outbreak of hantavirus pulmonary syndrome, Los Santos, Panama, 1999-2000. Emerg Infect Dis (2004) 1.17
Phylogenetic and geographical relationships of hantavirus strains in eastern and western Paraguay. Am J Trop Med Hyg (2006) 1.16
Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol (2007) 1.13
The Syrian hamster model of hantavirus pulmonary syndrome. Antiviral Res (2012) 1.10
Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog (2010) 1.08
Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells. Virology (2008) 1.06
VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. J Virol (2010) 1.02
Analysis of hantavirus genetic diversity in Argentina: S segment-derived phylogeny. J Virol (2002) 1.02
Hantaviruses in the americas and their role as emerging pathogens. Viruses (2010) 1.02
Antagonism of type I interferon responses by new world hantaviruses. J Virol (2010) 1.00
Hantavirus infection in humans and rodents, northwestern Argentina. Emerg Infect Dis (2003) 0.99
Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerg Infect Dis (2010) 0.99
Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. J Virol (2006) 0.98
Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerg Infect Dis (2014) 0.97
Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerg Infect Dis (2008) 0.97
Incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis (2006) 0.97
Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J Virol (2009) 0.94
In vitro and in vivo activity of ribavirin against Andes virus infection. PLoS One (2011) 0.93
First reported case of imported hantavirus pulmonary syndrome in europe. Emerg Infect Dis (2002) 0.93
Clusters of hantavirus infection, southern Argentina. Emerg Infect Dis (2007) 0.93
Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain. J Virol (2010) 0.92
High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis (2013) 0.92
Modeling to predict cases of hantavirus pulmonary syndrome in Chile. PLoS Negl Trop Dis (2014) 0.89
NMR structure of the N-terminal coiled coil domain of the Andes hantavirus nucleocapsid protein. J Biol Chem (2008) 0.88
Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Res (2008) 0.86
Effects of mefloquine use on Plasmodium vivax multidrug resistance. Emerg Infect Dis (2014) 0.86
Truncated hantavirus nucleocapsid proteins for serotyping Sin Nombre, Andes, and Laguna Negra hantavirus infections in humans and rodents. J Clin Microbiol (2010) 0.84
Spatial but not temporal co-divergence of a virus and its mammalian host. Mol Ecol (2011) 0.84
Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. Emerg Infect Dis (2000) 0.83
Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive. J Virol (2012) 0.82
Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus. Viruses (2013) 0.82
Hantavirus regulation of type I interferon responses. Adv Virol (2012) 0.81
Glaciation effects on the phylogeographic structure of Oligoryzomys longicaudatus (Rodentia: Sigmodontinae) in the southern Andes. PLoS One (2012) 0.81
An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein. MBio (2014) 0.81
Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells. Antiviral Res (2013) 0.81
The Role of the Endothelium in HPS Pathogenesis and Potential Therapeutic Approaches. Adv Virol (2012) 0.80
Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway. J Virol (2013) 0.79
Hantavirus Pulmonary Syndrome in the United States. Curr Infect Dis Rep (2001) 0.79
Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure. PLoS Negl Trop Dis (2015) 0.78
Development of a novel plaque reduction neutralisation test for hantavirus infection. Mem Inst Oswaldo Cruz (2015) 0.78
Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis. J Virol (2014) 0.77
Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches. Lymphat Res Biol (2013) 0.77
Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus. Clin Infect Dis (2015) 0.77
Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters. Viruses (2014) 0.76
Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A. PLoS One (2016) 0.76
Endocytic Pathways Used by Andes Virus to Enter Primary Human Lung Endothelial Cells. PLoS One (2016) 0.75
Knowledge, attitudes, and practices regarding hantavirus disease and acceptance of a vaccine trial in rural communities of southern Chile. Hum Vaccin Immunother (2016) 0.75
The Andes Virus Nucleocapsid Protein Directs Basal Endothelial Cell Permeability by Activating RhoA. MBio (2016) 0.75
Estimating hantavirus risk in southern Argentina: a GIS-based approach combining human cases and host distribution. Viruses (2014) 0.75
Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics. Diagn Microbiol Infect Dis (2015) 0.75
Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus. PLoS Negl Trop Dis (2017) 0.75
[Bilateral acute angle-closure glaucoma due to an infection with Hantavirus]. Ophthalmologe (2011) 0.75
Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America. J Clin Microbiol (2000) 1.94
Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol (2000) 1.70
Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile. Virus Res (1997) 1.61
Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina (B Aires) (1996) 1.56
Development of a murine model of chronic Salmonella infection. Infect Immun (1997) 1.22
Topical corticosteroid in normal patients and glaucoma suspects. Arch Ophthalmol (1967) 0.99
Andes virus associated with hantavirus pulmonary syndrome in northern Argentina and determination of the precise site of infection. Am J Trop Med Hyg (2002) 0.96
Coexistence of subtypes B, F, and as B/F env recombinant of HIV type 1 in Buenos Aires Argentina. AIDS Res Hum Retroviruses (1996) 0.93
Complete nucleotide sequence of the M RNA segment of Andes virus and analysis of the variability of the termini of the virus S, M and L RNA segments. J Gen Virol (2002) 0.85
[Epidemic outbreak of Hantavirus pulmonary syndrome in Argentina. Molecular evidence of person to person transmission of Andes virus]. Medicina (B Aires) (1998) 0.84
Peliosis hepatis in hematologic disease. Report of two cases. JAMA (1978) 0.82
High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment. Ann Rheum Dis (2009) 0.80
Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients. Diabete Metab (1995) 0.79
Relationship between Junin virus infection of thymus and the establishment of persistence in rodents. Med Microbiol Immunol (1986) 0.78
Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group. Eur J Endocrinol (1995) 0.78
LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group. Atherosclerosis (2000) 0.78
Different integrated and unintegrated HIV-1 DNA after superinfection and cell to cell transmission. Acta Physiol Pharmacol Ther Latinoam (1997) 0.76
Pituitary glycoprotein hormones in chronic renal failure: evidence for an uncontrolled alpha-subunit release. J Endocrinol Invest (1993) 0.76
Postirradiation hemangiosarcoma of the chest wall. Report of a case. Acta Radiol Oncol (1985) 0.75
The medical therapy of hemorrhagic complications following coronary artery bypass grafting. Arch Intern Med (1991) 0.75
[Lipids of Candida lipolytica cultivated in n-alkanes by the industrial method ("Toprina")]. Boll Soc Ital Biol Sper (1979) 0.75
Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1. Arch Virol (2005) 0.75
[Various aspects of experimental infection of the guinea pig with an attenuated variant of Junin virus]. Medicina (B Aires) (1981) 0.75
Junín virus persistence in mice. Acta Virol (1987) 0.75
Psychological tests: their use and validity in selecting candidates for schools of nursing in Israel. Int J Nurs Stud (1974) 0.75
Modification of Junin virus neurotropism in mice by selective brain or spinal cord passaging. Intervirology (1986) 0.75
[Development of the infection in guinea pigs infected with the attenuated variant XJO of Junín virus]. Rev Argent Microbiol (1983) 0.75
The oxygen affinity of normal human whole blood measured by double tonometry. II. pH-depending Bohr effect and DPG. Boll Soc Ital Biol Sper (1984) 0.75
Oxytocin and prostaglandins F2alpha and E2 do not enhance HIV antigen production in vitro. Arch Virol (2003) 0.75
[A new plaque assay for the quantification of Junin virus]. Rev Argent Microbiol (1982) 0.75
[Different clinical manifestations of suckling mice inoculated with various strains of Junin virus]. Medicina (B Aires) (1983) 0.75
Identification of human immunodeficiency virus type 1 subtypes B and F B/F recombinant and dual infection with these subtypes in Argentina. Scand J Infect Dis (1999) 0.75
Presence of human T-cell lymphotropic virus types I and II and coinfection with human immunodeficiency virus in different groups at risk in Argentina. J Acquir Immune Defic Syndr (1993) 0.75
[Association of the infection of the thymus and bone marrow with the establishment of persistent infection with Junin virus in 2 genera of rodents]. Rev Argent Microbiol (1985) 0.75
An instrument to diagnose personality types according to the personality theory of Shoham. Med Law (1987) 0.75
Obituary. Isr Ann Psychiatr Relat Discip (1975) 0.75
Reactivity of Argentine serum samples against synthetic V3-based HIV-1 peptides. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.75
The oxygen affinity of normal human whole blood measured by double tonometry. I. P50 and n factor. Boll Soc Ital Biol Sper (1984) 0.75